Predictors of response to anifrolumab in cutaneous lupus erythematosus: a prospective cohort study of 57 Patients - Supplementary Material

Description

Predictors of response to anifrolumab in cutaneous lupus erythematosus: a prospective cohort study of 57 Patients - Supplementary Material Table S1. Clinical and biological characteristics of patients at anifrolumab initiation Table S2. Factors associated with CLASI-70 response at 6 months after anifrolumab initiation Figure S3.Retention rate according to presence of cutaneous involvement Table S4. Treatment discontinuation rates and adverse events Table S5. Individual motives for treatment discontinuation Supplementary materials S6. Materials and methods for assessment of interferon gene signature

Categories

Licence